Cargando...
Cancer nanomedicine meets immunotherapy: opportunities and challenges
Cancer nanomedicines have shown promise in combination immunotherapy, thus far mostly preclinically but also already in clinical trials. Combining nanomedicines with immunotherapy aims to reinforce the cancer-immunity cycle, via potentiating key steps in the immune reaction cascade, namely antigen r...
Gardado en:
| Publicado en: | Acta Pharmacol Sin |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Singapore
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470866/ https://ncbi.nlm.nih.gov/pubmed/32555445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-0448-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|